0001144204-15-056162.txt : 20150923 0001144204-15-056162.hdr.sgml : 20150923 20150923171149 ACCESSION NUMBER: 0001144204-15-056162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150921 FILED AS OF DATE: 20150923 DATE AS OF CHANGE: 20150923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 BUSINESS ADDRESS: STREET 1: 24 WEST 40TH STREET STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 24 WEST 40TH STREET STREET 2: 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shaw Allan CENTRAL INDEX KEY: 0001626850 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36288 FILM NUMBER: 151121551 MAIL ADDRESS: STREET 1: C/O CELSUS THERAPEUTICS PLC STREET 2: 24 WEST 40TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 4 1 v420832_4.xml OWNERSHIP DOCUMENT X0306 4 2015-09-21 0 0001541157 Akari Therapeutics Plc AKTX 0001626850 Shaw Allan C/O AKARI THERAPEUTICS PLC 24 WEST 40TH STREET, 8TH FLOOR NEW YORK NY 10018 1 0 0 0 Options to Purchase Ordinary Shares 0.3221 2015-09-21 4 A 0 45000 0 A 2016-09-21 2025-09-21 Ordinary Shares 45000 45000 D Options to Purchase Ordinary Shares 0.3221 2015-09-21 4 A 0 186278 0 A 2016-09-21 2025-09-21 Ordinary Shares 186278 186278 D All shares underlying the options will vest on September 21, 2016 and expire 10 years from issuance. /s/ Dov Elefant, as attorney-in-fact 2015-09-23